Canada markets closed

Bionomics Limited (BNOX)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
0.9634+0.0217 (+2.30%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 10.28M
Enterprise Value 1.52M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)602.44
Price/Book (mrq)0.53
Enterprise Value/Revenue 68.93
Enterprise Value/EBITDA -0.05

Trading Information

Stock Price History

Beta (5Y Monthly) -0.08
52-Week Change 3-59.28%
S&P500 52-Week Change 325.59%
52 Week High 36.4100
52 Week Low 30.8400
50-Day Moving Average 31.0286
200-Day Moving Average 31.6023

Share Statistics

Avg Vol (3 month) 3117.39k
Avg Vol (10 day) 338.29k
Shares Outstanding 510.69M
Implied Shares Outstanding 68.16M
Float 81.28B
% Held by Insiders 10.00%
% Held by Institutions 121.31%
Shares Short (Apr 15, 2024) 4165.56k
Short Ratio (Apr 15, 2024) 40.99
Short % of Float (Apr 15, 2024) 42.00%
Short % of Shares Outstanding (Apr 15, 2024) 41.55%
Shares Short (prior month Mar 15, 2024) 458.18k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-9,466.24%

Management Effectiveness

Return on Assets (ttm)-35.13%
Return on Equity (ttm)-80.80%

Income Statement

Revenue (ttm)661.98k
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)9.30%
Gross Profit (ttm)N/A
EBITDA -25.72M
Net Income Avi to Common (ttm)-31.01M
Diluted EPS (ttm)-2.0300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.87M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)1.57M
Total Debt/Equity (mrq)5.41%
Current Ratio (mrq)3.81
Book Value Per Share (mrq)2.71

Cash Flow Statement

Operating Cash Flow (ttm)-26.64M
Levered Free Cash Flow (ttm)-13.58M